IBOV 192,114.55 ▲ 2.63% IPSA 10,916.57 ▲ 0.08% IPC MEX 64,531.68 ▲ 1.10% MERVAL 2,767,663 ▲ 0.32% COLCAP 2,515.02 ▼ 0.59% BVL PERÚ 59,751.67 ▲ 0.18% USD/BRL4.96▼ 4.93% USD/MXN18.12▼ 0.26% USD/CLP991.71▲ 0.12% USD/COP3,264▲ 0.30% USD/PEN3.45▲ 0.29% USD/ARS1,524▼ 0.04% USD/UYU40.46▲ 3.63% USD/PYG5,821▲ 3.10% USD/BOB11.93▲ 1.99% USD/DOP59.75▼ 0.25% USD/CRC456.38▲ 2.99% USD/GTQ7.64▲ 3.13% USD/HNL26.86▲ 3.18% USD/NIO36.62— 0.00% USD/VES869.19▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.69▲ 1.65% EUR/BRL5.57▼ 5.33% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 192,114.55 ▲ 2.63% IPSA 10,916.57 ▲ 0.08% IPC MEX 64,531.68 ▲ 1.10% MERVAL 2,767,663 ▲ 0.32% COLCAP 2,515.02 ▼ 0.59% BVL PERÚ 59,751.67 ▲ 0.18% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Monday, October 5, 2026

Business - Brazil Latest News

Xenobots: The Dawn of Living Machines and the Ethical Frontier of Bioengineering

By · October 19, 2024 · 3 min read

Scientists have created “xenobots,” microscopic living machines made from frog cells. These tiny organisms, less than a millimeter wide, blend biology and technology in a new way. They are designed by algorithms and assembled from the cells of the African clawed frog, *Xenopus laevis*.

Xenobots move independently and can perform simple tasks. Researchers believe they could transform medicine and environmental science. In the medical field, xenobots might deliver drugs directly to specific areas in the body. They could navigate through bodily fluids to target diseased cells or help in tissue repair.

Environmental applications are promising as well. Xenobots could collect microplastics from oceans, helping to clean polluted waters. Their biodegradable nature means they would not leave harmful residues behind. Scientists also consider using them to neutralize radioactive waste, reducing environmental hazards.

[arve url=”https://www.riotimesonline.com/wp-content/uploads/1729/32/Xenobots_-Scientists-build-first-living-robots-that-can-make-babies.mp4″ /]

These self-healing living machines offer a new platform for scientific research. They help scientists understand how cells work together and organize themselves. This knowledge could advance regenerative medicine and tissue engineering, leading to breakthroughs in healing damaged organs.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil runoff set: Flávio 47%, Lula 45%, 25 October”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

However, xenobots raise important ethical questions. Some people worry about creating new life forms and the consequences of altering natural organisms. The use of embryonic stem cells in their development adds to the debate. Concerns arise about their moral status and whether they should have any rights.

Safety is another significant issue. There is a risk that xenobots could malfunction or behave in unexpected ways. If released into natural environments, they might disrupt ecosystems. Scientists must consider the long-term effects and establish controls to prevent unintended consequences.

Xenobots: The Dawn of Living Machines and the Ethical Frontier of Bioengineering

Regulating xenobots presents challenges because they do not fit into existing categories of organisms or machines. New guidelines are needed to oversee their development and use. International cooperation may be necessary to address these regulatory gaps.

Currently, xenobots have limitations. They survive for only a few weeks and can perform only simple tasks. Continuous production is required for ongoing use. Improving their longevity and capabilities is a focus of future research.

Xenobots: The Dawn of Living Machines and the Ethical Frontier of Bioengineering.
Xenobots: The Dawn of Living Machines and the Ethical Frontier of Bioengineering.
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Xenobots represent a significant step in bioengineering. They hold the potential to revolutionize medicine and environmental cleanup. Yet, it is crucial to approach their development with caution. Addressing ethical, safety, and regulatory concerns is essential as we explore their possibilities.

These tiny living machines open new doors in science but also remind us of the responsibilities that come with innovation. Balancing progress with careful consideration will determine how xenobots shape our future.

This article was drafted with automated assistance and reviewed before publication. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.